Stay updated with breaking news from Given Halberd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Halberd (OTCMKTS:HALB – Get Rating) is one of 441 public companies in the “Biotechnology” industry, but how does it weigh in compared to its peers? We will compare Halberd to related companies based on the strength of its profitability, earnings, risk, analyst recommendations, dividends, valuation and institutional ownership. Earnings and Valuation This table compares Halberd […]
Halberd (OTCMKTS:HALB – Get Rating) is one of 371 publicly-traded companies in the “Biotechnology” industry, but how does it compare to its competitors? We will compare Halberd to similar businesses based on the strength of its analyst recommendations, dividends, risk, institutional ownership, earnings, profitability and valuation. Profitability This table compares Halberd and its competitors’ net […]
Halberd (OTCMKTS:HALB – Get Rating) is one of 344 public companies in the “Biotechnology” industry, but how does it contrast to its competitors? We will compare Halberd to similar companies based on the strength of its analyst recommendations, valuation, profitability, risk, earnings, dividends and institutional ownership. Valuation and Earnings This table compares Halberd and its […]
Halberd (OTCMKTS:HALB – Get Rating) is one of 348 publicly-traded companies in the “Biotechnology” industry, but how does it contrast to its rivals? We will compare Halberd to similar companies based on the strength of its analyst recommendations, valuation, institutional ownership, profitability, earnings, dividends and risk. Earnings & Valuation This table compares Halberd and its […]
Halberd (OTCMKTS:HALB – Get Rating) is one of 348 public companies in the “Biotechnology” industry, but how does it compare to its peers? We will compare Halberd to related businesses based on the strength of its dividends, risk, earnings, profitability, analyst recommendations, valuation and institutional ownership. Institutional & Insider Ownership 24.9% of shares of all […]